Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05365087 · ClinicalTrials.gov registry record
Transoral Fundoplication Prior to Sleeve Gastrectomy Versus RNY Gastric Bypass on GERD Symptoms in Bariatric Patients
A clinical trial of Gastroesophageal Reflux Disease, sponsored by Lexington Health Incorporated.
- Active
- Registry status
- 180
- Enrollment target
- 1
- Study location
NCT05365087 is a study of Gastroesophageal Reflux Disease that is active but no longer recruiting, run by Lexington Health Incorporated. The registered enrollment target is 180 participants, below the 340-participant average among 24 other Gastroesophageal Reflux Disease trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05365087, a study of Gastroesophageal Reflux Disease, is active but no longer recruiting, sponsored by Lexington Health Incorporated.
- ACTIVE NOT RECRUITING
- Registry status
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
A retrospective and prospective cohort study to compare the effect of completing a Transoral Fundoplication procedure prior to Laparoscopic Sleeve Gastrectomy surgery to Laparoscopic Roux-en-Y Gastric Bypass in bariatric patients with Gastroesophageal Reflux Disease signs and symptoms. The aim of this study is to examine the effect of TF prior to sleeve gastrectomy as compared to Roux-en-Y Gastric Bypass on reflux symptoms in bariatric patients. Additional Follow up data until 10 years will be collected to evaluate for sequelae of GERD.
Conditions Studied
Interventions
- PROCEDURE Transoral Fundoplication and Sleeve Gastrectomy
- PROCEDURE Gastric Bypass
Study Locations (1)
South Carolina
- Lexington Health Incorporated - West Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2032-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05365087
The ClinicalTrials.gov registry entry for NCT05365087 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 340-participant average among 24 other Gastroesophageal Reflux Disease trials with a reported enrollment target (47% lower). The listed sponsor is Lexington Health Incorporated, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastroesophageal Reflux Disease appearing as the primary indexed condition, and to 2 interventions - of which Transoral Fundoplication and Sleeve Gastrectomy is the first listed.
NCT05365087 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT05365087 about?
NCT05365087 is a clinical study titled "Transoral Fundoplication Prior to Sleeve Gastrectomy Versus RNY Gastric Bypass on GERD Symptoms in Bariatric Patients". A retrospective and prospective cohort study to compare the effect of completing a Transoral Fundoplication procedure prior to Laparoscopic Sleeve Gastrectomy surgery to Laparoscopic Roux-en-Y Gastric Bypass in bariatric patients with Gastroesophageal Reflux Disease signs and symptoms. The aim of th...
What is the current status of trial NCT05365087?
This trial is currently active not recruiting. The enrollment target is 180 participants. The study started on 2018-03-01. Estimated completion is 2032-12-31.
What conditions does trial NCT05365087 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux Disease.
What interventions are being tested in trial NCT05365087?
The interventions under investigation include: Transoral Fundoplication and Sleeve Gastrectomy (PROCEDURE), Gastric Bypass (PROCEDURE).
Who is sponsoring clinical trial NCT05365087?
This trial is sponsored by Lexington Health Incorporated, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05365087 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
-
Domperidone in Treating Patients With Gastrointestinal Disorders
RECRUITING · Phase 3
-
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
ACTIVE NOT RECRUITING
-
GCC Agonist Signal in the Small Intestine
ACTIVE NOT RECRUITING · Phase 1
-
Morphological Markers of Gastroesophageal Reflux Disease (GERD)
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.